Prof. Markel is a Clinician and basic researcher, he is the Chief Scientist of the Ella Lemelbaum Institute for Immuno-Oncology, Sheba medical center and Associate Professor of Immunology (Tel Aviv University). Prof. Markel is an expert in Immuno-Oncology with broad experience in integrative platforms, including genetics, cell biology, animal models and immunology. He is the […]
Ronit is a general partner at Evergreen, focuses on investments in the healthcare sector. Since 2014 she is also an early stage private investor. Before joining Evergreen, Ronit served as Vice President of Pharmos Ltd. (NASDAQ: PARS). Prior to that Ronit held senior positions at InterPharm Ltd. (Israel) and Ares-Serono (Switzerland). Ronit is a member […]
Clinical consultant and SAB member, Deputy Director of the Perlmutter Cancer Center and Codirector of its Melanoma Program at NYU Langone Medical Center. Medical oncologist and translational clinical trialist with an interest in melanoma immunotherapy and its intersection with targeted therapy.
Physician-scientist and former Head of Translational Medicine at Roche/Genentech, with broad experience in drug early and late clinical development from over 50 programs. Dr. Pisa has in-depth knowledge of the experimental and clinical challenges with real-life experience of successful translation of scientific findings into medicines and innovative treatment modalities. Dr. Pisa has behind him a […]
Dr. Sidransky has served as a member of our Board of Directors since 2017. He is a renowned oncologist and research scientist named and profiled by TIME magazine in 2001 as one of the top physicians and scientists in America, recognized for his work with early detection of cancer. Since 1994, Dr. Sidransky is the […]
Guy has served as a member of our Board of Directors since 2018. Guy is an entrepreneur and investor and has invested and worked with multiple successful companies including Lemonade (LMND:NYSE), Innoviz (INVZ:NASDAQ), American Well (AMWL:NYSE), Ecoppia (ECPA:TLV, Ayala Pharma (AYLA:NASDAQ), Quantum Machines, Tabit, Assured Allies and Oxford Nanopore. Guy was the Co-Founder and CEO […]
Dr. Zeldis was appointed to our Board of Directors in June 2020. He is Executive Chair of ViralClear Pharmaceuticals, Inc. and previously served as Chief Medical Officer and President of Clinical Research, Medical Affairs, Drug Safety, Quality, and Regulatory at Sorrento Therapeutics, Inc. Prior to Sorrento he had a nearly 20-year career at Celgene during […]